Von Gierke Disease

K. Bennett*, A. Burchell

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Glycogen storage diseases (GSDs) are autosomal recessive metabolic disorders resulting in storage of abnormal amounts and/or forms of glycogen. Von Gierke disease is a GSD caused by defective liver and kidney glucose-6-phosphatase activity and is named after the pathologist who first described excess glycogen storage in the liver. The disease-causing mutation(s) can be either in the gene coding for the liver glucose-6-phosphatase enzyme (G6PC) or in the gene coding for the endoplasmic reticulum substrate and/or product transport proteins of the glucose-6-phosphatase system. The two common forms of GSD1 are termed GSD1a and GSD1b, and are caused by deficiency in G6PC and the glucose-6-phosphate transporter (G6PT1), respectively. The disease is currently managed by nocturnal nasogastric infusion of glucose and/or cornstarch mixed into drinks during the day, but compliance is often low. Recent advances in the use of gene therapy in animal models of the disease provide hope for this approach in the treatment of human patients in the future.

Original languageEnglish
Title of host publicationBrenner's encyclopedia of genetics
EditorsStanley Maloy, Kelly Hughes
Place of PublicationLondon
PublisherAcademic Press
Pages304-307
Number of pages4
Edition2
ISBN (Electronic)9780080961569
ISBN (Print)9780123749840
DOIs
Publication statusPublished - 27 Feb 2013
Externally publishedYes

Fingerprint

Glycogen Storage Disease Type I
Glucose-6-Phosphatase
Glycogen Storage Disease
Glycogen
Liver
Animal Disease Models
Endoplasmic Reticulum
Genetic Therapy
Starch
Genes
Compliance
Carrier Proteins
Kidney
Glucose
Mutation
Enzymes
Therapeutics

Cite this

Bennett, K., & Burchell, A. (2013). Von Gierke Disease. In S. Maloy, & K. Hughes (Eds.), Brenner's encyclopedia of genetics (2 ed., pp. 304-307). London: Academic Press. https://doi.org/10.1016/B978-0-12-374984-0.01631-4
Bennett, K. ; Burchell, A. / Von Gierke Disease. Brenner's encyclopedia of genetics. editor / Stanley Maloy ; Kelly Hughes. 2. ed. London : Academic Press, 2013. pp. 304-307
@inbook{7669611c9ce1415ea236cff350bd3dc3,
title = "Von Gierke Disease",
abstract = "Glycogen storage diseases (GSDs) are autosomal recessive metabolic disorders resulting in storage of abnormal amounts and/or forms of glycogen. Von Gierke disease is a GSD caused by defective liver and kidney glucose-6-phosphatase activity and is named after the pathologist who first described excess glycogen storage in the liver. The disease-causing mutation(s) can be either in the gene coding for the liver glucose-6-phosphatase enzyme (G6PC) or in the gene coding for the endoplasmic reticulum substrate and/or product transport proteins of the glucose-6-phosphatase system. The two common forms of GSD1 are termed GSD1a and GSD1b, and are caused by deficiency in G6PC and the glucose-6-phosphate transporter (G6PT1), respectively. The disease is currently managed by nocturnal nasogastric infusion of glucose and/or cornstarch mixed into drinks during the day, but compliance is often low. Recent advances in the use of gene therapy in animal models of the disease provide hope for this approach in the treatment of human patients in the future.",
author = "K. Bennett and A. Burchell",
year = "2013",
month = "2",
day = "27",
doi = "10.1016/B978-0-12-374984-0.01631-4",
language = "English",
isbn = "9780123749840",
pages = "304--307",
editor = "Stanley Maloy and Kelly Hughes",
booktitle = "Brenner's encyclopedia of genetics",
publisher = "Academic Press",
edition = "2",

}

Bennett, K & Burchell, A 2013, Von Gierke Disease. in S Maloy & K Hughes (eds), Brenner's encyclopedia of genetics. 2 edn, Academic Press, London, pp. 304-307. https://doi.org/10.1016/B978-0-12-374984-0.01631-4

Von Gierke Disease. / Bennett, K.; Burchell, A.

Brenner's encyclopedia of genetics. ed. / Stanley Maloy; Kelly Hughes. 2. ed. London : Academic Press, 2013. p. 304-307.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Von Gierke Disease

AU - Bennett, K.

AU - Burchell, A.

PY - 2013/2/27

Y1 - 2013/2/27

N2 - Glycogen storage diseases (GSDs) are autosomal recessive metabolic disorders resulting in storage of abnormal amounts and/or forms of glycogen. Von Gierke disease is a GSD caused by defective liver and kidney glucose-6-phosphatase activity and is named after the pathologist who first described excess glycogen storage in the liver. The disease-causing mutation(s) can be either in the gene coding for the liver glucose-6-phosphatase enzyme (G6PC) or in the gene coding for the endoplasmic reticulum substrate and/or product transport proteins of the glucose-6-phosphatase system. The two common forms of GSD1 are termed GSD1a and GSD1b, and are caused by deficiency in G6PC and the glucose-6-phosphate transporter (G6PT1), respectively. The disease is currently managed by nocturnal nasogastric infusion of glucose and/or cornstarch mixed into drinks during the day, but compliance is often low. Recent advances in the use of gene therapy in animal models of the disease provide hope for this approach in the treatment of human patients in the future.

AB - Glycogen storage diseases (GSDs) are autosomal recessive metabolic disorders resulting in storage of abnormal amounts and/or forms of glycogen. Von Gierke disease is a GSD caused by defective liver and kidney glucose-6-phosphatase activity and is named after the pathologist who first described excess glycogen storage in the liver. The disease-causing mutation(s) can be either in the gene coding for the liver glucose-6-phosphatase enzyme (G6PC) or in the gene coding for the endoplasmic reticulum substrate and/or product transport proteins of the glucose-6-phosphatase system. The two common forms of GSD1 are termed GSD1a and GSD1b, and are caused by deficiency in G6PC and the glucose-6-phosphate transporter (G6PT1), respectively. The disease is currently managed by nocturnal nasogastric infusion of glucose and/or cornstarch mixed into drinks during the day, but compliance is often low. Recent advances in the use of gene therapy in animal models of the disease provide hope for this approach in the treatment of human patients in the future.

U2 - 10.1016/B978-0-12-374984-0.01631-4

DO - 10.1016/B978-0-12-374984-0.01631-4

M3 - Chapter

AN - SCOPUS:85043283654

SN - 9780123749840

SP - 304

EP - 307

BT - Brenner's encyclopedia of genetics

A2 - Maloy, Stanley

A2 - Hughes, Kelly

PB - Academic Press

CY - London

ER -

Bennett K, Burchell A. Von Gierke Disease. In Maloy S, Hughes K, editors, Brenner's encyclopedia of genetics. 2 ed. London: Academic Press. 2013. p. 304-307 https://doi.org/10.1016/B978-0-12-374984-0.01631-4